Acceptability, Representations and Experiences of an Application and Captors Which Suggest a Walking Itinerary
- Disease/Condition
- Aging
- Drug/Device/Intervention
- Individual interviews
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Location
- Saint-Étienne, France
- Phase
- N/A
- Start date
- Apr 01, 2021
- End date
- Dec 31, 2021
- Enrollment
- 24 participants
representations and acceptability about a potential application and captors which suggest a Walking itinerary
ParcourSenior is a project lead by School of Mines from Saint-Etienne, Gérontopôle AURA and
 Senior Autonomie to promote walking in a city environment. To enable that, we have two
 tools at your disposable. The first one is sensor which can measure physicals abilities. The
 second one is an application which proposes individual itineraries based on physical
 abilities. This application concern people whom want to walk alone, with supportive people or
 with new people encounter in this app. Both tools are in the process of being created. The
 current study focuses on needs, expectations and desire of the elders and professionals about
 both of these tools. After, we plan to focus on the acceptability of these devices. A
 qualitative study with focus groups is carried out to evaluate the needs and expectation
 follows by individual interviews to evaluate the project: acceptability, fears and use's
 perception.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05984355
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05984355 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Saint Etienne and is currently Completed. The study focuses on Aging. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.